Table 3

Genotype frequency distribution of the three polymorphisms



Normotensives n. 67
Hypertensives n. 127
p <

G894T
GG
(19/67) 28%
(45/127) 35.4%
n.s.

GT
(41/67) 61%
(70/127) 55.1%
n.s.

TT
(7/67) 11%
(12/127) 9.5%
n.s.

GT+TT
72%
61.6%
n.s.
Alleles

N°134
N°256


G
(79/134) 59%
(160/256) 63%
n.s.

T
(55/134) 41%
(94/256) 37%
n.s.









Normotensives n. 38
Hypertensives n. 107
p <

T786C
TT
(8/38) 21%
(25/107) 23%
n.s.

TC
(19/38) 50%
(51/107) 48%
n.s.

CC
(11/38) 29%
(31/107) 29%
n.s.

TC+CC
79%
78%
n.s.
Alleles

N°76
N°214


T
(35/76) 46%
(101/214) 47%
n.s.

C
(41/76)54%
(113/214) 53%
n.s.









Normotensives n. 31
Hypertensives n. 119
p <

introne 4
bb
(24/31) 77%
(86/119) 72.5%
n.s.

ba
(7/31) 23%
(30/119) 25%
n.s.

aa
(0/31) 0%
(3/119) 2.5%
0.005

ab+aa
23%
27.5%
n.s.
Alleles

N°62
N°238


b
(55/62) 89%
(202/238) 85%
n.s.

a
(7/62) 11%
(36/238) 15%
n.s.

Colomba et al. Immunity & Ageing 2008 5:4   doi:10.1186/1742-4933-5-4